enGene Therapeutics Inc.

ENGN·NasdaqCM·Healthcare
Compare
1.7200+0.1000 (+6.17%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market1.7400+0.0200 (+1.16%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.6200
Open1.5850
Day range1.58001.7500
52-week range1.400012.2500
Off day high−1.71%
Off 52-week high−85.96%
Volume1.45M
Avg. volume (3M)763.49K
Market cap115.27M
EPS (TTM)-2.07
Forward P/E-1.14
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.24
Shares outstanding67.02M
Short interest2.76% of float
Earnings dateSep 8, 2026 (est.)
Analyst target3.2857
Profit margin0.00%

Against its peers

Compare in full ›
ENGN ONCY TRDA CADL CSBR ACTI.ST
Market cap 115.27M 55.70M 197.02M 692.49M 67.23M 102.54M
P/E (TTM) — — — — — —
Forward P/E -1.1 -2.1 -1.6 -14.5 48.3 —
Price/book 0.5 -8.7 0.8 5.5 17.3 2.8
Dividend yield — — — — — —
1-year change −74.45% −58.42% −27.19% +83.20% −29.80% −42.74%
Today +6.17% +8.92% +7.20% +2.61% 0.00% +5.71%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ENGN news ›

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance